PMID: 11606250Oct 19, 2001Paper

NKp46

The International Journal of Biochemistry & Cell Biology
O Mandelboim, A Porgador

Abstract

Combating diseases such as cancer and virus infection is one of the major goals of the next millennium. Remarkably, our immune system has developed a unique cell type called Natural Killer (NK) cells, able to kill cancer and virus-infected cells. The nature of the lysis/killer receptors expressed on NK cells, mediating this killing, and their ligands, is only little understood. Four lysis receptors for human NK cells were recently identified, including the NKp30, NKp44, NKp46 and CD16, all of which are capable of mediating direct killing of virus-infected and tumor cells. Among these, the NKp46 receptor is considered to be the major lysis receptor for NK cells. The viral hemagglutinin protein was recently identified as the ligand for the NKp46 receptor. However, the cellular (non-viral) ligands recognized by all of the lysis receptors (NKp30, NKp44, NKp46 and CD16) are currently unknown.

References

Jul 1, 1990·Immunology Today·H G Ljunggren, K Kärre
May 23, 1998·Annual Review of Immunology·L L Lanier
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·O MandelboimJ L Strominger
Jun 8, 1999·Annual Review of Immunology·E O Long

❮ Previous
Next ❯

Citations

Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Jareer KassisAlan Wells
Feb 18, 2006·Cancer Immunology, Immunotherapy : CII·Rafael SolanaRaquel Tarazona
Jun 23, 2010·Immunology and Cell Biology·Hollie J PegramMichael H Kershaw
Apr 20, 2006·Nature Immunology·Thomas Spies, Veronika Groh
Mar 3, 2011·The Journal of Clinical Investigation·Jianhua YuMichael A Caligiuri
Nov 5, 2010·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yui Harada, Yoshikazu Yonemitsu
Mar 15, 2011·Critical Reviews in Immunology·Peter D KruegerYoung S Hahn
Nov 2, 2007·The Journal of Investigative Dermatology·Emanuela CagnanoAngel Porgador
Jan 5, 2011·Scandinavian Journal of Immunology·H ShirzadM Shirzad
Apr 25, 2012·Journal of Immunotoxicology·Michael BrusilovskyAngel Porgador
Mar 24, 2011·Expert Opinion on Biological Therapy·Gunnur Deniz, Mubeccel Akdis
Dec 25, 2003·Leukemia & Lymphoma·Cyril FauriatRégis T Costello
Sep 3, 2013·The Journal of Allergy and Clinical Immunology·Günnur DenizMübeccel Akdis
May 19, 2010·Expert Review of Clinical Immunology·Esin AktasGunnur Deniz
Apr 24, 2018·The Journal of General Virology·Samantha McQuaidPatricia Johnson
Nov 30, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bryan SimonsKevan Roberts
Dec 22, 2017·Cancer Immunology, Immunotherapy : CII·Avishai ShemeshAngel Porgador
Jan 29, 2019·American Journal of Reproductive Immunology : AJRI·Koushi Yamaguchi
Jan 29, 2020·Clinical and Experimental Immunology·S L McQuaidP A Johnson
Nov 16, 2007·Clinical and Vaccine Immunology : CVI·Brian R LongDouglas F Nixon
Sep 13, 2019·Cancer Immunology, Immunotherapy : CII·Vasiliki SiozopoulouPatrick Pauwels
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Noga BloushtainAngel Porgador
Apr 9, 2021·Scientific Reports·Aner OttolenghiAngel Porgador
Feb 7, 2009·Journal of Proteome Research·Marie-Lyn HechtPeter H Seeberger
Aug 28, 2021·Cells·Mohamed KhalilSubramaniam Malarkannan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.